Back to Journal

SM Journal of Hematology & Oncology

Prevalence of Anemia and Hematological Profiles among Medical Students at Sana’a University: A High Altitude Cross-Sectional Study

Abstract Citation INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION CONCLUSIONS RECOMMENDATIONS ETHICAL APPROVAL ACKNOWLEDGMENT REFERENCES
Details

Received: 02-May-2026

Accepted: 30-May-2026

Published: 31-May-2026

Ghadeer Y. Al-Anssi1, Khater Gh. H. AL-Hamoodi2, Mubarak Gh. H. AL-Hamoodi3, Tibyan Abd Almajed Altaher4, and Ghanem Mohammed Mahjaf5*

1Faculty of Medicine and Health Sciences, Sana’a University, Yemen

2Department of Haematology, Faculty of Medical Laboratory Sciences, University of Thamar, Yemen

3Department of Medicine and Surgery, Faculty of Medicine, Shendi University, Sudan

4Department of Clinical Chemistry, Faculty of Medical Laboratory Sciences, Shendi University, Sudan

5Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, Shendi University, Sudan

Corresponding Author:

Ghanem Mohammed Mahjaf, Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, Shendi University, Sudan

Keywords

Anemia; Medical Students; Sana’a University; Hemoglobin; High Altitude; Yemen.

Abstract

Background: Anemia remains a significant global public health challenge. However, its prevalence among health professions students residing in high-altitude regions—where physiological adaptations may alter standard hematological parameters—is not well documented. This study aimed to determine the prevalence of anemia and evaluate the complete hematological profiles of medical students at Sana’a University, Yemen, a city situated at approximately 2,250 meters above sea level. Methods: A cross-sectional study was conducted among 100 undergraduate students (51 males and 49 females) aged 19–25 years at the Faculty of Medicine and Health Sciences, Sana’a University. Venous blood samples were collected and analyzed for Complete Blood Count (CBC) parameters using an automated Sysmex XN-330 hematology analyzer. Anemia was initially defined according to the World Health Organization (WHO) sea-level criteria (hemoglobin [Hb]

Results: The overall mean hemoglobin concentration was 15.63 ± 1.73 g/dL. Sex-stratified analysis revealed significantly higher mean Hb levels in males (16.96 ± 1.20 g/dL) compared to females (14.24 ± 0.91 g/dL) (p < 0.001). Other mean hematological indices were as follows: packed cell volume (PCV) 47.05 ± 4.73%, Red Blood Cell (RBC) count 5.43 ± 0.59 × 10¹²/L, Mean Corpuscular Volume (MCV) 86.39 ± 7.63 fL, and Mean Corpuscular Hemoglobin (MCH) 28.82 ± 2.24 pg. Using the unadjusted WHO sea-level criteria, the prevalence of anemia in this cohort was 0%. However, applying the recommended WHO altitude adjustment for Sana’a (+1.0 g/dL) revises the diagnostic thresholds to 14.0 g/dL for males and 13.0 g/dL for females, potentially identifying anemic cases, particularly among female participants. Conclusion: No anemia was detected in this sample of medical students using standard sea-level criteria, a finding likely attributable to high health literacy and physiological adaptation to Sana’a’s altitude. This study highlights the critical need to establish altitude-specific hematological reference ranges for the Yemeni population to prevent the misdiagnosis of anemia in high-altitude regions.

Citation

Al-Anssi GY, AL-Hamoodi KGH, AL-Hamoodi MGH, Altaher TAA, Mahjaf GM. (2026) Prevalence of Anemia and Hematological Profiles among Medical Students at Sana’a University: A High-Altitude Cross-Sec tional Study. SM J Hematol Oncol 8(1): 1019.

INTRODUCTION

Anemia is a major global public health concern and a common clinical manifestation of diverse underlying pathological conditions. It is characterized by a reduction in Red Blood Cell (RBC) count and/or Hemoglobin (Hb) concentration, ultimately leading to impaired oxygen delivery to body tissues and subsequent physiological dysfunction [1,2]. The burden of anemia extends beyond clinical symptoms, as it is associated with reduced physical performance, impaired cognitive function, decreased productivity, and increased morbidity, particularly among young and economically active populations. Despite decades of research and global health initiatives, anemia continues to affect a substantial proportion of the world’s population. The World Health Organization (WHO) recognizes anemia as a critical indicator of both nutritional status and overall population health. However, the accurate diagnosis of anemia remains challenging due to variations in environmental, physiological, and demographic factors. One of the most important yet often overlooked determinants is altitude. Individuals residing at high altitudes experience physiological adaptations, including increased hemoglobin concentration, as a compensatory response to reduced oxygen partial pressure. Consequently, the use of standard sea level diagnostic thresholds in such settings may lead to misclassification, either underestimating or overestimating the true burden of anemia [3,4]. The etiology of anemia is complex and frequently multifactorial. Iron deficiency remains the most common cause globally, accounting for nearly half of all cases [5,6]. Nevertheless, other contributing factors—including micronutrient deficiencies (such as vitamin B12 and folate), chronic infections, inflammatory conditions, and blood loss—play significant roles, particularly in low- and middle-income countries. Among young adults, menstrual blood loss, suboptimal dietary intake, and lifestyle related factors further contribute to the risk of anemia. Medical students constitute a unique population that may be particularly susceptible to anemia despite their relatively high level of health awareness. The demanding nature of medical education is often associated with chronic stress, irregular eating habits, sleep deprivation, and reduced physical activity. These factors, combined with potential financial constraints and limited access to balanced nutrition in resource-limited settings, may increase vulnerability to hematological abnormalities [7,8]. Importantly, existing evidence indicates that higher educational status does not necessarily confer protection against anemia, underscoring the need for targeted assessment even within academically privileged groups [9-12]. The burden of anemia is disproportionately higher in developing countries, where it remains a persistent and multifaceted public health challenge [13-19]. In Yemen, the situation is further aggravated by prolonged conflict, economic instability, and a deteriorating healthcare infrastructure. These conditions have significantly impacted food security and nutritional status, thereby increasing the population’s susceptibility to anemia and other micronutrient deficiencies. Furthermore, Sana’a, the capital city of Yemen, is located at an altitude of approximately 2,250 meters above sea level. This high-altitude environment introduces an additional layer of complexity in the interpretation of hematological parameters. Although the WHO recommends altitude-specific adjustments for hemoglobin thresholds, such corrections are not consistently applied in clinical practice or research settings, particularly in low-resource countries. This gap may lead to inaccuracies in prevalence estimates and hinder effective public health interventions. Given these considerations, there is a clear need for context-specific investigations that account for both environmental and population-specific factors. Therefore, this study aimed to determine the prevalence of anemia and comprehensively evaluate the hematological profiles of medical students at Sana’a University. In addition, it sought to assess the impact of applying altitude-adjusted hemoglobin thresholds on anemia classification in this high-altitude urban population, thereby contributing to more accurate diagnosis and improved epidemiological understanding.

MATERIALS AND METHODS

Study Design and Setting

A cross-sectional study was conducted at the Faculty of Medicine and Health Sciences, Sana’a University, Sana’a, Yemen. Sana’a is situated at an altitude of approximately 2,250 meters above sea level, a factor known to influence hematological parameters, particularly hemoglobin concentration. The study was carried out over a two-month period, from January to February 2024, under standardized environmental and laboratory conditions to ensure data consistency.

Study Population and Sampling

The study population consisted of 100 undergraduate students (51 males and 49 females) aged between 19 and 25 years. Participants were recruited using a simple random sampling technique from multiple academic departments, including Human Medicine, Pharmacy, Nursing, and Medical Laboratory Sciences, to ensure representation of diverse health-related disciplines.

Inclusion criteria included apparently healthy students within the specified age group who agreed to participate voluntarily. Individuals with known chronic diseases, recent infections, or those currently taking medications that could affect hematological parameters were excluded from the study to minimize potential confounding factors.

All participants were informed about the purpose and procedures of the study, and written informed consent was obtained before enrollment, in accordance with ethical research standards.

Data Collection and Laboratory Analysis

Approximately 3 mL of venous blood was collected aseptically from each participant using sterile disposable syringes and transferred into K3 EDTA anticoagulant vacutainer tubes. All samples were properly labeled and processed on the same day of collection to avoid pre-analytical variations. Complete Blood Count (CBC) analysis was performed using a calibrated Sysmex XN-330 automated hematology analyzer at the AULAQI Specialized Medical Laboratory in Sana’a. This analyzer is widely recognized for its precision and reliability in hematological assessments. Strict internal quality control measures were implemented daily using control samples, and the laboratory adhered to Standard Operating Procedures (SOPs) to ensure the accuracy, reproducibility, and validity of the results.

Diagnostic Criteria

Anemia was initially defined based on the World Health Organization (WHO) hemoglobin cut-off values at sea level: Hemoglobin (Hb) concentration <13.0 g/dL for adult males and <12.0 g/dL for non pregnant adult females. Considering the high-altitude location of Sana’a, an adjustment factor of +1.0 g/dL was taken into account for interpretative and discussion purposes, in line with WHO recommendations for populations residing at elevated altitudes. This adjustment is essential to avoid overestimation of anemia prevalence in high-altitude settings due to physiological increases in hemoglobin levels.

Statistical Analysis

Data were entered, cleaned, and analyzed using IBM SPSS Statistics version 24.0. Descriptive statistics were computed for all variables, including means, Standard Deviations (SD), and ranges for continuous data. Inferential statistical analysis was performed using the independent samples t-test to compare mean hematological parameters between male and female participants. A p-value of less than 0.05 was considered statistically significant.

RESULTS

A total of 100 undergraduate students participated in this study, including 51 males (51%) and 49 females (49%), with a mean age of 22.77 ± 1.73 years. The overall hematological parameters of the study population are presented in Table 1.

Table 1: Overall Hematological Parameters of the Study Population

Parameter

Mean ± SD

Hb (g/dL)

15.63 ± 1.73

PCV (%)

47.05 ± 4.74

RBC (×10¹²/L)

5.43 ± 0.60

MCV (fL)

86.39 ± 7.63

MCH (pg)

28.83 ± 2.24

MCHC (g/dL)

33.19 ± 1.07

The mean hemoglobin concentration was 15.63 ± 1.73 g/dL. Other hematological parameters included packed cell volume (47.05 ± 4.74%), red blood cell count (5.43 ± 0.60 × 10¹²/L), mean corpuscular volume (86.39 ± 7.63 fL), mean corpuscular hemoglobin (28.83 ± 2.24 pg), and mean corpuscular hemoglobin concentration (33.19 ± 1.07 g/dL). Sex-based comparisons are presented in Table 2. Male participants demonstrated significantly higher mean hemoglobin, PCV, and RBC values compared to females (p < 0.001). However, no significant difference was observed in MCV values between the two groups (p = 0.08). Based on WHO sea-level criteria, no cases of anemia were identified in the study population. However, after applying altitude adjusted hemoglobin cut-offs, several female participants were found to have hemoglobin values close to the diagnostic threshold, suggesting possible underestimation of anemia prevalence when standard sea-level criteria are used.

Table 2: Comparison of Hematological Parameters Between Male and Female Participants

Parameter

Males (n=51) Mean ± SD

Females (n=49) Mean ± SD

p-value

Hb (g/dL)

16.96 ± 1.20

14.24 ± 0.91

<0.001

PCV (%)

50.66 ± 3.27

43.29 ± 2.60

<0.001

RBC (×10¹²/L)

5.76 ± 0.55

5.08 ± 0.41

<0.001

MCV (fL)

87.68 ± 6.90

85.06 ± 8.20

0.08

DISCUSSION

This study aimed to assess the prevalence of anemia and evaluate hematological profiles among medical students in Sana’a, a high-altitude city in Yemen. The principal finding was a 0% prevalence of anemia when applying the standard World Health Organization (WHO) sea-level criteria. The mean hemoglobin levels observed—16.96 g/dL for males and 14.24 g/dL for females—were notably higher than the global averages reported for similar age groups [7]. The most plausible explanation for the elevated hemoglobin levels observed in this study is physiological adaptation to the high altitude of Sana’a (~2,250 meters above sea level). At higher altitudes, reduced atmospheric oxygen pressure stimulates erythropoiesis, leading to increased hemoglobin concentration and red blood cell production in order to enhance oxygen delivery to tissues [20]. This adaptive mechanism explains the relatively high hemoglobin values recorded, with some male participants reaching levels as high as 19.2 g/ dL. While such levels may suggest polycythemia in low-altitude settings, they are generally considered normal among individuals residing long term at high altitudes [21,22]. The use of universal sea-level hemoglobin cut-offs in high-altitude populations remains controversial [23-26]. The WHO recommends adjusting hemoglobin thresholds upward by approximately 0.8–1.3 g/dL for populations living at elevations between 2,000 and 2,500 meters [27]. Applying a conservative adjustment of +1.0 g/dL in this study would increase the diagnostic thresholds to 14.0 g/ dL for males and 13.0 g/dL for females. Under these adjusted criteria, all male participants would still be classified as non-anemic. However, some female participants, particularly those with hemoglobin values close to 12.0 g/dL, may be reclassified as anemic. This finding suggests that the reported 0% anemia prevalence may be underestimated due to the use of unadjusted diagnostic thresholds. It highlights the importance of applying altitude-specific criteria when assessing anemia in high-altitude populations. The findings of this study differ from those reported by Nassar et al. (2021), who documented a 4.5% prevalence of anemia among final-year medical students at Sana’a University [20]. This discrepancy may be attributed to differences in sample characteristics, study design, or temporal changes in nutritional status and health awareness among students. In contrast, studies conducted in low-altitude regions of Yemen, such as Hodeida, have reported significantly higher prevalence rates of anemia (30.4%) [28]. This variation underscores the combined influence of environmental and socioeconomic factors on hematological parameters. While altitude promotes increased erythropoiesis, factors such as malnutrition, infection, and limited access to healthcare contribute to higher anemia prevalence in lower-altitude and resource limited settings [22-30]. One of the main strengths of this study is its focus on a high-altitude population, which provides valuable insight into hematological adaptations in such environments. Additionally, the use of an automated hematology analyzer ensured accurate and reliable measurement of hematological parameters. However, several limitations should be acknowledged. First, the relatively small sample size (n = 100) may limit the generalizability of the findings to the broader student population or the general Yemeni population. Second, the study did not include biochemical markers of iron status, such as serum ferritin or transferrin saturation, which are essential for confirming iron deficiency anemia. Furthermore, inflammatory markers such as C-reactive protein were not assessed, which may have helped differentiate between anemia of chronic disease and iron deficiency anemia. The absence of these parameters limits the ability to fully interpret the underlying causes of potential anemia cases.

CONCLUSIONS

In conclusion, this study found no cases of anemia among a sample of medical students in Sana’a when using standard, sea-level WHO criteria. This finding is likely a combined result of the participants’ high health literacy and the physiological erythropoietic response to living at high altitude. However, the application of recommended altitude-adjusted thresholds would potentially identify cases of anemia, particularly in females, highlighting the critical need for context-specific diagnostic approaches.

RECOMMENDATIONS

Based on the findings of this study, it is recommended to establish population-specific, altitude-adjusted hematological reference ranges for individuals living in high-altitude regions such as Sana’a to improve the accuracy of anemia diagnosis. Clinical laboratories should incorporate altitude-corrected hemoglobin thresholds into routine reporting to avoid misclassification. Furthermore, future research should include larger and more representative sample sizes, as well as comprehensive biochemical markers such as serum ferritin and inflammatory indicators, to better distinguish between physiological adaptation and true anemia. Additionally, periodic screening programs among university students are encouraged to ensure early detection and prevention of hematological abnormalities.

ETHICAL APPROVAL

This study was conducted in accordance with the Declaration of Helsinki. The research protocol was approved by the Ethics Committee of the Faculty of Medicine, Sana’a University. Written informed consent was obtained from all participants after a full explanation of the study’s purpose and procedures. Participant confidentiality was ensured through the use of anonymized codes for all data.

ACKNOWLEDGMENT

The authors would like to express their sincere gratitude to the Faculty of Medicine and Health Sciences at Sana’a University for their support. Special thanks are extended to the AULAQI Specialized Medical Laboratory and the National Center of Public Health for their invaluable technical assistance. Finally, the authors are deeply grateful to all students who voluntarily participated in this study.

REFERENCES

1. Freeman AM, Zubair M. Anemia screening. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.

2. Karakochuk CD, Hess SY, Moorthy D, Namaste S, Parker ME, Rappaport AI, et al. Measurement and interpretation of hemoglobin concentration in clinical and field settings: a narrative review. Ann N Y Acad Sci. 2019; 1450: 126-146.

3. Lin TF, Huang JN, Cash HL. Investigation of pediatric anemia in the commonwealth of the Northern Mariana Islands. Matern Child Health J. 2019; 23: 416-421.

4. Dhabangi A, Idro R, John CC, Dzik WH, Opoka R, Ssenyonga R, et al. Risk factors for recurrent severe anemia among previously transfused children in Uganda: An age-matched case-control study. BMC Pediatr. 2019; 19: 27.

5. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: WHO; 2011.

6. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015; 372: 1832-1843.

7. Bhanderi DN, Ramana NP, Babariya KA. Prevalence and Risk Factors of Anemia among Undergraduate Medical Students. Eur J Cardiovasc Med. 2025; 15: 68-70.

8. Wangaskar SA, Sahu SK, Majella MG, Rajaa S. Prevalence of anaemia and compliance to weekly iron-folic acid supplementation programme amongst adolescents in selected schools of urban Puducherry, India. Niger Postgrad Med J. 2021; 28: 44-50.

9. Cappellini MD, Beris P. Anemia in Clinical Practice: Introduction. Semin Hematol. 2015; 52: 259-260.

10. Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, et al. Diagnosis and management of iron deficiency anaemia: A clinical update. Med J Aust. 2010; 193: 525-532.

11. Horjus P, Aguayo VM, Roley JA, Pene MC, Meershoek SP. School-based iron and folic acid supplementation for adolescent girls: Findings from Manica Province, Mozambique. Food Nutr Bull. 2005; 26: 281-286.

12. Kaur S, Deshmukh PR, Garg BS. Epidemiological correlates of nutritional anemia in adolescent girls of rural Wardha. Indian J Commu Med. 2006; 31: 255.

13. Araujo Costa E, de Paula Ayres-Silva J. Global profile of anemia during pregnancy versus country income overview: 19 years estimative (2000-2019). Ann Hematol. 2023; 102: 2025-2031.

14. Hakami W, Dobie G, Alneami KA, Shaabi M, Essawi K, Saboor M, et al. Assessing nutritional anemia among university students in Jazan, Saudi Arabia: A Public Health Perspective. J Blood Med. 2024; 15: 51-60.

15. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009; 12: 444-454.

16. Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: A systematic analysis of population-representative data. Lancet Glob Health. 2013; 1: e16-25.

17. Pasricha SR. Anemia: A comprehensive global estimate. Blood. 2014;123: 611-612.

18. Kassebaum NJ; GBD 2013 Anemia Collaborators. The Global Burden of Anemia. Hematol Oncol Clin North Am. 2016; 30: 247-308.

19. Shah SP, Shah P, Desai S, Modi D, Desai G, Arora H. Effectiveness and Feasibility of weekly iron and folic acid supplementation to adolescent girls and boys through peer educators at community level in the tribal area of Gujarat. Indian J Community Med. 2016; 41: 158-161.

20. Pitkin F. Haemoglobin Profiles of University Students Participating in Routine Medical Examinations, 2009-2011. Arch Clin Biomed Res. 2017; 1: 209-216.

21. Bärtsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation. 2007; 116: 2191-2202.

22. Beall CM. Adaptation to high altitude: phenotypes and genotypes.Annu Rev Anthropol. 2014; 43: 251-272.

23. Nassar MY, Hudna AS, Abdurubbu F. Anemia and Its Associated Factors among Final-Year Medical Students at Sana’a University, Yemen. Yemeni J Med Sci. 2021; 15: 45-52.

24. Mairbäurl H, Kilian S, Seide S, Muckenthaler MU, Gassmann M, Benedict RK. The Increase in Hemoglobin concentration with altitude differs between world regions and is less in children than in adults. Hemasphere. 2023; 7: e854.

25. Gonzales GF, Begazo J, Alarcón-Yaquetto DE. Suitability of Haemoglobin Adjustment to Define Anaemia at High Altitudes. Acta Haematol. 2020; 143: 511-512.

26. Alkhaldy HY, Awan ZA, Abouzaid AA, Elbahaey HM, Al Amoudi SM, Shehata SF, et al. Effect of Altitude on Hemoglobin and Red Blood Cell Indices in Adults in Different Regions of Saudi Arabia. Int J Gen Med. 2022; 15: 3559-3565.

27. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity: altitude adjustment recommendations. Geneva: WHO; 2011.

28. Al-Alimi AA, Bashanfer S, Morish MA. Prevalence of iron deficiency anemia among university students in hodeida province, Yemen. Anemia. 2018; 2018: 4157876.

29. Al-Zabedi EM, Kaid FA, Sady H. Prevalence and risk factors of iron deficiency anemia among children in Yemen. Am J Health Res. 2014; 2: 319-326.

30. Al-Jermmy ASM, Idris SM, Coulibaly-Zerbo F, Nasreddine L, Al-Jawaldeh A. Prevalence and Correlates of anemia among adolescents living in Hodeida, Yemen. Children (Basel). 2022; 9: 977.

Citation

Al-Anssi GY, AL-Hamoodi KGH, AL-Hamoodi MGH, Altaher TAA, Mahjaf GM. (2026) Prevalence of Anemia and Hematological Profiles among Medical Students at Sana’a University: A High-Altitude Cross-Sec tional Study. SM J Hematol Oncol 8(1): 1019.

Other Articles

Article Image 1

High Throughput siRNA Screen Identifies LRP8 as Druggable Metabolic Regulator in Triple-Negative Breast Cancer

Background: Triple-Negative Breast Cancers (TNBC) overexpress a large number of genes compared to other breast cancer subtypes and these genes represent potential therapeutic targets.

Methods: We identified genes overexpressed in TNBC compared in public gene expression data sets and performed an siRNA screen with 4 distinct constructs against each of 681 overexpressed genes in 18 breast cancer cell lines. The top tier hits were assessed in functional and mechanistic studies to validate their role in the growth and survival of TNBC cells in vitro and in vivo.

Results: Low density Lipoprotein Receptor-Related Protein 8 (LRP8) and Very Low-Density Lipoprotein Receptor (VLDLR) was the top two ranked hits based on 3 of 4 siRNAs showing, significant and preferential growth inhibition in TNBC cell lines. Apolipoprotein E isoform 4 (ApoE4), and to a lesser extent rellin, which are ligands of both LRP8 and VLDLR stimulated the growth of TNBC cells in vitro in a receptor-dependent manner. Suppression of LRP8 or VLDLR expression or exposure to a ligand inhibitor, RAP abolished this ligandinduced proliferation. Metabolic profiling (with GC/MS and LC/MSMS) and reverse phase protein arrays (n=230 antibodies/201 proteins) revealed that ApoE4 stimulation rescued TNBC cells from serum-starvation, induced up-regulation of genes involved in lipid biosynthesis and increased protein expression of genes involved in the MAPK/ERK and DNA repair pathways.

Conclusion: LRP8 is overexpressed in TNBC and promotes cell growth and survival under nutrient depleted conditions through stimulating lipid biosynthetic pathways. Inhibitors of LRP8/VLDLR signaling represent potential new therapeutic targets for TNBC.

Banu Arun¹, Soley Bayraktar¹, Christine Shiang⁴, Yuan Qi², Bailiang Wang¹, Angelica GB¹, Fraser SW³, Liem Phan⁵, Mong-Hong Lee⁵, Yun Wu³, Gabriel NH¹, Vikram W⁶ and Lajos P⁶*


Article Image 1

Is Warfarin Obsolete?

Warfarin, the vitamin K antagonist, was the only one oral anticoagulant available over the last six decades for clinical use. Recently, though there has been an introduction of Newer Oral Anti Coagulants (NOACs) such as dabigatron, rivaraxoban, apixaban and edoxaban. These NOACs have changed the landscape for prophylaxis and treatment of Venous Thrombo Embolism (VTE) and non valvular atrial fibrillation

Visweshwar N¹*, Malachowski S¹, Jaglal M² and Laber D²


Article Image 1

GSK-3? and its Unexpected Role in Immunity, Inflammation and Cancer

Glycogen Synthase Kinase-3β (GSK-3β) is a key component of a complex array of cellular processes. Several mechanisms are involved in controlling its activity, including phosphorylation, protein complex formation and sub cellular distribution. Aberrant GSK-3β action has been implicated in many diseases and disorders, such as cancer, heart disease, metabolic and neurological disorders. More recently, GSK-3β has been identified as a crucial regulator of the balance between pro and anti-inflammatory cytokine production. This review will highlight the immunological importance of GSK-3β and the latest discoveries that led to the identification of a new central role of GSK-3β in tumor immunity.

Serena De Matteis¹, Roberta Napolitano¹ and Silvia Carloni¹*


Article Image 1

H.pylori Infection as Risk Factor for GIT Bleeding in Haemophilic Patients

Background: Helicobacter pylori is endemic in Egypt and present a main cause of gastrointestinal bleeding.

Aim: this study is to evaluate the prevalence of H.pylori infection in hemophilic patients, and to assess its impact on gastrointestinal bleeding associated with this infection in such patients.

Methods: we prospectively investigated the prevalence of H.pylori infection in 40 Egyptian patients with Hemophilia -A, -B and VonWillebrand syndrome and 20 normal male subjects was included. Every patient and control subject in the study was tested one time for H.pylori stool antigen by ELISA. All patients and control subjects were tested for occult blood using Guaiac-based fecal occult blood test. Results: Twenty eight out of 40 patients (70%) are H. pylori positive; and 12 out of 20 controls (60%) are H. pylori positive. The odds ratio is ‎1.55, 95% CI (0.6162 to 3.9269), ‎Significance level P=0.3497. Among 28 H.pylori positive patients, 5 patients (17.9 %) tested positive for occult blood. Among the 12 H.pylori positive subjects ‎ in the‎ control group, only one tested positive for occult blood (8.3%). Odds ratio for Occult bleeding in H pylori positive patients and control was 2.39: P=0.4504. None of the H.pylori negative patients or control subjects had a positive occult blood disease. Conclusion: patients with hemophilia, H. pylori should not be considered as an important cause of GI bleeding. The recurrence of the infection and GI bleeding could be prevented with eradication of H.pylori. Screening tests for H. pylori would not be needed in patients with hemophilia in endemic areas.

Noha M. El Husseiny¹*, Louis Essac and Mona Al Kassas


Article Image 1

Evaluation of CD 25 (IL2 Receptor Alpha) Expression in Adult Acute Lymphoblastic Leukemia Patients

Background: Many parameters are included to determine the risk stratification of Acute Lymphoblastic Leukemia (ALL), Philadelphia Chromosome (Ph)/BCR-ABL–positive (ALL) is the largest genetically defined subtype in adult ALL with poor outcome. Here, we detected IL-2Rα (CD25) in patients with ALL and explored its diagnostic and prognostic value.

Patients and methods : Thirty ALL patients were recruited in Egypt , newly diagnosed with ages above 18 years old, after informed consent they invited to perform CD25 marker using Coulter EPICSXL, PCR for BCR – ABL fusion gene and Fluorescence in Situ Hybridization (FISH) were also performed along with CBC, LDH, Uric acid, CT scan allover and testicular ultrasonography.

Results: (70%) of patients were males while (30%) were females with no statistically significant difference as correlated with CD25, 13 (43. 33%) patients had positive CD25 , recurrent infections had occurred in 8 patients (26. 67%) with no significant correlation with CD25 (P = 0. 361), 16(53. 33%) patients suffered from fever, while 5 (16. 67%) experienced bleeding with no significant correlation among them with CD 25 (P> 0.05 in both). FISH cytology and PCR were positive in 11 (36.67%) patients. There was highly statistically significant correlation among CD25 and FISH and PCR for BCR-ABL, LDH, total leucocytic count with (P value <0.001). We showed that CD25 measurements compare favorably with other ALL prognostic criteria.

Conclusion: (CD25) expression was corresponding to Philadelphia chromosome. IL-2R α (CD25) is proved to be a valuable marker for monitoring ALL patients, an important parameter for prognosis and follow-up of ALL patients

Inas Ahmed Asfour¹, Gihan Mohamed Kamal Shams El Din¹, Rasha Magdy Mohammed Said¹* and Entessar Mabrook Juadam²


Article Image 1

Hemophagocytic Lymphohistiocytosis, A Syndrome of Excessive Immune Activation: Review of the Literature

Hemophagocytic Lymphohistiocytosis (HLH) is a rare and life threatening syndrome caused by excessive and dis-regulated immune activation. It can present as a primary sporadic disorder or be secondary to a trigger disrupting the immune homeostasis, such as auto-immune disorders, malignancies and mainly infections. It is usually of low suspicion index, and has variable presentations lacking specific pathognomonic clinical or laboratory signs. HLH is a medical emergency, and is associated with poor prognosis in most of the cases. An early diagnosis and initiation of appropriate treatment may change the outcome. Here I present a review of the literature concerning HLH, and one related pathologically similar disorder, the Macrophage Activation Syndrome (MAS), emphasizing on the clinical presentation, associated etiologies, diagnosis, treatment and prognosis, thus making the clinicians more aware of this fatal syndrome in order to decrease the related mortality.

Georges EI Hachem¹*


Article Image 1

Osteosarcoma of the Distal Tibia

Osteosarcoma more frequently occurs in children and adolescents, at the position of knee-joint and proximal humerus.

Yufeng Chen¹*


Article Image 1

Clinical and Laboratory Analysis of Patients with Multiple Myeloma: Five-Year Experience

Background: Multiple myeloma (MM) is characterized by clonal expansion of plasma cell in the bone marrow and production of monoclonal immunoglobulin, with bone destruction, renal failure and suppression of the normal hematopoiesis. Identification of clinical factors and laboratory diagnosis is important to characterize the stage of the disease and estimate survival.

Objective: To identify clinical and laboratory diagnosis of patients with multiple myeloma treated at HEMOPE - Foundation of Hematology and Hematology of Pernambuco.

Methods: This was an observational, transversal study with secondary data obtained from medical records. A descriptive analysis of clinical and laboratory features and prognostic factors of 112 patients diagnosed with multiple myeloma was conducted from January 2010 to December 2014.

Results: The median age was 65 years, of these 49.1% were male and 50.9% female. The most common clinical manifestations were: bone pain (70.5%), weight loss (25%) and weakness (23.2%). Anemia has been observed at diagnosis in 75% of patients and hypercalcemia in 15.2%. Regarding the staging system at diagnosis, 94 (83.9%) patients were classified as stage III Durie-Salmon and 32 (28.6%) patients in stage II of the International Staging System (ISS).

Conclusion: Our found in this study were similar to previous reported in the literature. A good characterization of the patient’s diagnosis and the use of accurate diagnostic methods are the ideal approach for better risk classification, therapeutic choice and follow-up of patients with MM.

Duarte BP¹˒², De Souza Junior VR¹˒³*, Assis RA²˒⁴, Barros Correia CW¹˒², Hazin MF¹˒²˒⁴, and Correia MCB¹˒²


Article Image 1

Cauda Equina Involvement in Newly Diagnosed Myeloma Patient

Cauda Equina Syndrome (CES) is a rare complication of Multiple Myeloma (MM) that is a clonal plasma cell disorders. We presented a case who newly diagnosed MM which complicated with cauda equina involvement. A 51-year-old woman admitted to our hospital because of weakness and low back pain. Neurological examination demonstrated sphincter dysfunction, decreased Achilles tendon reflexes, frust hemiparesia, reflected CES. Laboratory analysis was revealed anemia, hipergammaglobulinemia and monoclonal peak in the protein electrophoresis. Magnetic resonance imaging (MRI) of the spine showed multiple vertebral compression fractures and marked contrast enhancement of the cauda equina region. The patient was diagnosed MM with bone marrow biopsy. After VAD treatment, MRI showed disappearance of infiltration. Although, there are some case reports with cauda equina involvement in myeloma patient, we could not find any case presenting with CES in newly diagnosed MM. This rare complication should be remembered in myeloma patients who presented symptoms of CES.

Demet Cekdemir¹˒²*, Nur Soyer¹, Halil Gulluoglu³, Gulgun Yilmaz Ovali⁴, and Mahmut Tobu¹


Article Image 1

Stem Cell Transplant for Multiple Myeloma: A Single Center Experience from Northern India

Autologous Stem Cell Transplantation (ASCT) is the preferred treatment for the management of multiple myeloma after initial 4-6 months of induction treatment.

Sanjeev Kumar Sharma*, Dharma Choudhary, Meet Kumar, Vipin Khandelwal, Divya Doval, Anil Handoo, Rasika Setia, and Tina Dadu